Companies
Benchmark Genetics
supplies disease-free Atlantic salmon ova to the global industry every week of the year from its SalmoBreed program — 25 years old in 2026 — and reported in February 2026 that cross-generational genomic selection markedly raised resistance to cardiomyopathy syndrome (CMS),…
- Country
- Norway
Commercial
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| livestock-aqua | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaefsamoa-china
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Capacity | continuous, year-round production of Atlantic salmon ova | bmkgenetics.com · seafoodsource.com |
| Certification | GLOBAL G.A.P., EFFAB, ISO, Organic (Debio/Tun), RSPCA (Freedom Food) | bmkgenetics.com |
| Production site | Benchmark Genetics Salten (Norway), Lønningdal, Bolaks, and facilities in Iceland, Chile, USA, and Colombia | hatcheryfm.com · bmkgenetics.com · hatcheryinternational.com · seafoodsource.com |
| Headcount | 89 (as of 2024/2025) | 21st.ai · bedriftsoversikten.no · companybook.co |
| Revenue | 479.4 million NOK (2025) | 21st.ai · biztrac.no · regnskapstall.no |
Independent sources: 21st.ai · bedriftsoversikten.no · biztrac.no · bmkgenetics.com · companybook.co · hatcheryfm.com · hatcheryinternational.com · regnskapstall.no · seafoodsource.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Aquaculture & fish farming | livestock-aqua | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.